New Delhi, Dec 19 (PTI) The Competition Commission of India (CCI) on Tuesday said it cleared Nirma's acquisition of majority shareholding of Glenmark Life Sciences Ltd.

The combination relates to the acquisition of majority shareholding of Glenmark Life Sciences Limited by Nirma Ltd.

Also Read | SBI Clerk Prelims Exam 2023: Admit Card for Preliminary Examination of Junior Associates Likely To Be Released Soon at sbi.co.in, Know How To Download.

Glenmark Life Sciences Ltd (GLS) is engaged in the business of development, manufacturing and sale of Active Pharmaceutical Ingredients (APIs) and intermediaries and contract development and manufacture organisation (CDMO) services for APIs.

"CCI approves acquisition of majority shareholding of the Glenmark Life Sciences Limited by the Nirma Ltd," the competition watchdog said in a post on social media platform X on Tuesday.

Also Read | DU Recruitment 2023: Vacancies Notified for 51 Assistant Professor Posts, Apply Online at colrec.uod.ac.in.

Ahmedabad-based Nirma is known for its detergents, soap, and dishwashing bars. It is also into the manufacturing of industrial products like soda ash, linear alkyl benzene, alfa olefin sulphonates, fatty acid, glycerine, and sulphuric acid.

In September this year, Glenmark Pharmaceuticals said its board has approved to divest 75 per cent stake in its subsidiary GLS to Nirma Ltd for Rs 5,651.5 crore.

The deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices as well as promotes fair competition in the marketplace.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)